Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model

被引：0

作者：

Bianco, Thiago Mantello ^{[1
]}

Coelho-Silva, Juan L. ^{[2
,3
,4
]}

Pereira-Martins, Diego A. ^{[2
,5
]}

Scheucher, Priscila Santos ^{[1
]}

Weinhauser, Isabel ^{[2
]}

Alves Silva, Antonio Bruno ^{[1
,2
]}

Silva, Cleide Lucia ^{[2
]}

Mullally, Ann ^{[6
]}

Kobayashi, Susumu S. ^{[7
,8
]}

Rego, Eduardo M. ^{[2
,9
]}

Traina, Fabiola ^{[1
,2
]}

Figueiredo-Pontes, Lorena Lobo ^{[1
,2
]}

机构：

[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Div Hematol, Dept Med Images Hematol & Clin Oncol, Ribeirao Preto, Brazil

[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Cell Based Therapy & Reg Hemotherapy Ctr, Ribeirao Preto, SP, Brazil

[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Hematol Div Med Images, Ribeirao Preto, Brazil

[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Oncol Dept, Ribeirao Preto, Brazil

[5] Univ Sao Paulo, Med Sch Ribeirao Preto, Div Hematol, Dept Internal Med, Ribeirao Preto, Brazil

[6] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA

[7] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] Univ Sao Paulo, Med Sch, Hosp Clin, Div Hematol,Fac Med HCFMUSP, Sao Paulo, Brazil

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2977

引用

页数：3

共 50 条

[31] Imbalance between Tolerant and Cytotoxic Functional Subsets of NK Cells in a JAK2V617F Myeloproliferative Neoplasm Model
Bianco, Thiago Mantello
Arantes, Adriana Queiroz
Lopes, Izabela Aparecida
Scheucher, Priscila Santos
Silva, Cleide Araujo
Mullally, Ann
Kobayashi, Susumu S.
Rego, Eduardo Magalhaes
Figueiredo-Pontes, Lorena Lobo
BLOOD, 2017, 130
[32] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
Xu, Na
Ding, Li
Yin, Changxin
Zhou, Xuan
Li, Lin
Li, Yulin
Lu, Qisi
Liu, Xiao-li
ANNALS OF HEMATOLOGY, 2015, 94 (05) : 865 - 867
[33] JAK2V617F influences epigenomic changes in myeloproliferative neoplasms
Chen, Chih-Cheng
Chiu, Chia-Chen
Lee, Kuan-Der
Hsu, Chia-Chen
Chen, Hong-Chi
Huang, Tim H. -M.
Hsiao, Shu-Huei
Leu, Yu-Wei
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 494 (3-4) : 470 - 476
[34] EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS
Uras, A.
Fancello, M. A.
Monne, M.
Piras, G.
Palmas, A. D.
Gaviano, E.
Noli, A.
Bianchi, A.
Gabbas, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
[35] JAK2V617F allele burden in patients with myeloproliferative neoplasms
Salem H. Alshemmari
Reshmi Rajaan
Reem Ameen
Mohammad A. Al-Drees
Marwa R. Almosailleakh
Annals of Hematology, 2014, 93 : 791 - 796
[36] Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders
Marchetti, Marina
Falanga, Anna
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) : 148 - 159
[37] The JAK2V617F negative erythrocytosis: A distinctive myeloproliferative syndrome?
Di Gaetano, R.
Zanotto, D.
Belvini, D.
Salviato, R.
Pierobon, F.
De Biasi, E.
Radossi, P.
Risato, R.
Roveroni, G.
Sartori, R.
Tassinari, C.
Toffano, N.
Tagariello, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 168 - 168
[38] Identification of JAK2V617F Mutation on Myeloproliferative Disorders in Medan
Anggraini, Dwi Rita
Hidayat
Sitorus, Mega Sari
PROCEEDINGS OF THE 1ST PUBLIC HEALTH INTERNATIONAL CONFERENCE (PHICO 2016), 2016, 1
[39] The Study of Thrombosis in JAK2V617F Mutated Myeloproliferative Neoplasms
Bai, Jie
Zhang, Yuhui
Wang, Yingshao
Teng, Guangshuai
Wang, Yan
Du, Chenxiao
Chen, Yafang
Zhang, Huiqin
Li, Yanqi
Fu, Lixia
Zhang, Lei
Zhou, Yuan
BLOOD, 2019, 134
[40] Thrombosis in myeloproliferative neoplasia Influence of the mutation JAK2V617F
Guy, Alexandre
James, Chloe
M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 651 - 658

← 1 2 3 4 5 →